Abstract
Recent studies indicated that andrographolide was a potential anti-HIV therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their anti-HIV activities were evaluated in vitro. As compared with TI, compounds 5c, 5d and 5i showed moderate inhibitory activities on the cytopathic effect with TI above 10. Among the derivatives, compound 5i was the best one with TI > 51.
Keywords: Andrographolide, anti-HIV, derivatives, synthesis, cytopathic effect, HIV/AIDS, alkaloids, polysaccharides, flavonoids, triterpenes, lactones, sapon-ins, Andrographis paniculata, protein-mediated syncytia, HL60 cells, CD4+ lymphocyte level, HIV-1 RNA, lipopoly-saccharides (LPS)-induced tumor necrosis factor, interleukin-6, cyclooxygenase-2, acid anhydride, DMAP, CH2Cl2, propionic anhydride, hexanoic anhydride, benzoyl chloride, triphenylchloromethane, methylmorpholine, dicyclohexylcarbodiimide, C8166 cells, therapeutic index, anti-HIV-1 effects, hin-layer chromatography, DMSO, fetal bovine serum, 96-well microtiter plate, HIV-1 tissue culture infections dose
Medicinal Chemistry
Title: Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives
Volume: 6 Issue: 4
Author(s): Bin Wang, Liang Ge, Wenlong Huang, Huibin Zhang, Hai Qian, Jing Li and Yongtang Zheng
Affiliation:
Keywords: Andrographolide, anti-HIV, derivatives, synthesis, cytopathic effect, HIV/AIDS, alkaloids, polysaccharides, flavonoids, triterpenes, lactones, sapon-ins, Andrographis paniculata, protein-mediated syncytia, HL60 cells, CD4+ lymphocyte level, HIV-1 RNA, lipopoly-saccharides (LPS)-induced tumor necrosis factor, interleukin-6, cyclooxygenase-2, acid anhydride, DMAP, CH2Cl2, propionic anhydride, hexanoic anhydride, benzoyl chloride, triphenylchloromethane, methylmorpholine, dicyclohexylcarbodiimide, C8166 cells, therapeutic index, anti-HIV-1 effects, hin-layer chromatography, DMSO, fetal bovine serum, 96-well microtiter plate, HIV-1 tissue culture infections dose
Abstract: Recent studies indicated that andrographolide was a potential anti-HIV therapeutic agent. In the paper, the synthesis of a series of andrographolide derivatives was described and their anti-HIV activities were evaluated in vitro. As compared with TI, compounds 5c, 5d and 5i showed moderate inhibitory activities on the cytopathic effect with TI above 10. Among the derivatives, compound 5i was the best one with TI > 51.
Export Options
About this article
Cite this article as:
Wang Bin, Ge Liang, Huang Wenlong, Zhang Huibin, Qian Hai, Li Jing and Zheng Yongtang, Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives, Medicinal Chemistry 2010; 6 (4) . https://dx.doi.org/10.2174/1573406411006040252
DOI https://dx.doi.org/10.2174/1573406411006040252 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in the Management of Brain Tumors in Infants
Current Cancer Therapy Reviews Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents Engineering Antibodies for Therapy
Current Pharmaceutical Biotechnology Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine
Current Pharmaceutical Design Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results
Current Radiopharmaceuticals Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling
Current Pharmaceutical Design Telomerase Inhibitors as Anticancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Editorial [ Hot Topic: Targeting Tumor Angiogenesis: An Update (Guest Editor: Girolamo Ranieri)]
Current Medicinal Chemistry Small Peptides as Modulators of Serine Proteases
Current Medicinal Chemistry Stem Cell Genetic Therapy for Fanconi Anemia – A New Hope
Current Gene Therapy Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy
Current Pharmaceutical Design The PIK3CA Gene as a Mutated Target for Cancer Therapy
Current Cancer Drug Targets Bioinorganic Chemistry: The Study of the Fate of Platinum-Based Antitumour Drugs
Current Chemical Biology Chemistry and Biological Activity of [1,2,3]-Benzotriazine Derivatives
Current Organic Chemistry Molecular Testing and Personalized Treatment of Lung Cancer
Current Molecular Pharmacology Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Overview on Anticancer Drug Design and Development
Current Medicinal Chemistry Comparison of Large Proteomic Datasets
Current Proteomics